Beyond new chemical entities

References

• Cariuk P, Gardener MJ, Vaughan TJ. Evolution of biologics screening technologies. Pharmaceuticals (Basel) 2013; 6:681 - 8; http://dx.doi.org/10.3390/ph6050681; PMID: 24276173
   PubMedGoogle Scholar
• De Rosa L, Russomanno A, Romanelli A, D’Andrea LD. Semi-synthesis of labeled proteins for spectroscopic applications. Molecules 2013; 18:440 - 65; http://dx.doi.org/10.3390/molecules18010440; PMID: 23282535
   PubMed Web of Science ®Google Scholar
• Adelman B. Opening up drug development to everyone. Hematology Am Soc Hematol Educ Program 2013; 2013:311 - 5; http://dx.doi.org/10.1182/asheducation-2013.1.311; PMID: 24319197
   PubMed Web of Science ®Google Scholar
• Caoili SE. Antidotes, antibody-mediated immunity and the future of pharmaceutical product development. Hum Vaccin Immunother 2013; 9:294 - 9; http://dx.doi.org/10.4161/hv.22858; PMID: 23291934
   PubMed Web of Science ®Google Scholar
• Subbarayappa BV. The roots of ancient medicine: an historical outline. J Biosci 2001; 26:135 - 43; http://dx.doi.org/10.1007/BF02703637; PMID: 11426049
   PubMed Web of Science ®Google Scholar
• Schmidt B, Ribnicky DM, Poulev A, Logendra S, Cefalu WT, Raskin I. A natural history of botanical therapeutics. Metabolism 2008; 57:Suppl 1 S3 - 9; http://dx.doi.org/10.1016/j.metabol.2008.03.001; PMID: 18555851
   PubMed Web of Science ®Google Scholar
• Bosch F, Rosich L. The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize. Pharmacology 2008; 82:171 - 9; http://dx.doi.org/10.1159/000149583; PMID: 18679046
   PubMed Web of Science ®Google Scholar
• Nabel GJ. Designing tomorrow’s vaccines. N Engl J Med 2013; 368:551 - 60; http://dx.doi.org/10.1056/NEJMra1204186; PMID: 23388006
   PubMed Web of Science ®Google Scholar
• Yoneyama H, Katsumata R. Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci Biotechnol Biochem 2006; 70:1060 - 75; http://dx.doi.org/10.1271/bbb.70.1060; PMID: 16717405
   PubMed Web of Science ®Google Scholar
• Chen L, Lu J, Zhang J, Feng KR, Zheng MY, Cai YD. Predicting chemical toxicity effects based on chemical-chemical interactions. PLoS One 2013; 8:e56517; http://dx.doi.org/10.1371/journal.pone.0056517; PMID: 23457578
   PubMedGoogle Scholar
• Greek R, Pippus A, Hansen LA. The Nuremberg Code subverts human health and safety by requiring animal modeling. BMC Med Ethics 2012; 13:16; http://dx.doi.org/10.1186/1472-6939-13-16; PMID: 22769234
   PubMed Web of Science ®Google Scholar
• Gillon R. “Primum non nocere” and the principle of non-maleficence. Br Med J (Clin Res Ed) 1985; 291:130 - 1; http://dx.doi.org/10.1136/bmj.291.6488.130; PMID: 3926081
   PubMed Web of Science ®Google Scholar
• Waddell WJ. History of dose response. J Toxicol Sci 2010; 35:1 - 8; http://dx.doi.org/10.2131/jts.35.1; PMID: 20118619
   PubMed Web of Science ®Google Scholar
• Eddleston M, Persson H. Acute plant poisoning and antitoxin antibodies. J Toxicol Clin Toxicol 2003; 41:309 - 15; http://dx.doi.org/10.1081/CLT-120021116; PMID: 12807314
   PubMed Web of Science ®Google Scholar
• Pan Y, Gao D, Zhan CG. Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers. J Am Chem Soc 2008; 130:5140 - 9; http://dx.doi.org/10.1021/ja077972s; PMID: 18341277
   PubMed Web of Science ®Google Scholar
• Chmura AJ, Orton MS, Meares CF. Antibodies with infinite affinity. Proc Natl Acad Sci U S A 2001; 98:8480 - 4; http://dx.doi.org/10.1073/pnas.151260298; PMID: 11447282
   PubMed Web of Science ®Google Scholar
• Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood 2012; 119:2205 - 8; http://dx.doi.org/10.1182/blood-2011-04-347690; PMID: 22147890
   PubMed Web of Science ®Google Scholar
• Foote J, Eisen HN. Breaking the affinity ceiling for antibodies and T cell receptors. Proc Natl Acad Sci U S A 2000; 97:10679 - 81; http://dx.doi.org/10.1073/pnas.97.20.10679; PMID: 11005851
   PubMed Web of Science ®Google Scholar
• Gigant B, Charbonnier JB, Eshhar Z, Green BS, Knossow M. X-ray structures of a hydrolytic antibody and of complexes elucidate catalytic pathway from substrate binding and transition state stabilization through water attack and product release. Proc Natl Acad Sci U S A 1997; 94:7857 - 61; http://dx.doi.org/10.1073/pnas.94.15.7857; PMID: 9223277
   PubMed Web of Science ®Google Scholar
• Kolesnikov AV, Kozyr AV, Alexandrova ES, Koralewski F, Demin AV, Titov MI, Avalle B, Tramontano A, Paul S, Thomas D, et al. Enzyme mimicry by the antiidiotypic antibody approach. Proc Natl Acad Sci U S A 2000; 97:13526 - 31; http://dx.doi.org/10.1073/pnas.200360497; PMID: 11095704
   PubMed Web of Science ®Google Scholar
• Paul S, Planque S, Zhou YX, Taguchi H, Bhatia G, Karle S, Hanson C, Nishiyama Y. Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120. J Biol Chem 2003; 278:20429 - 35; http://dx.doi.org/10.1074/jbc.M300870200; PMID: 12665517
   PubMed Web of Science ®Google Scholar
• Hifumi E, Honjo E, Fujimoto N, Arakawa M, Nishizono A, Uda T. Highly efficient method of preparing human catalytic antibody light chains and their biological characteristics. FASEB J 2012; 26:1607 - 15; http://dx.doi.org/10.1096/fj.11-195339; PMID: 22205784
   PubMed Web of Science ®Google Scholar
• O’Hear CE, Foote J. Antibody buffering of a ligand in vivo. Proc Natl Acad Sci U S A 2005; 102:40 - 4; http://dx.doi.org/10.1073/pnas.0405797102; PMID: 15615858
   PubMed Web of Science ®Google Scholar
• Medeiros-Souza P, Santos-Neto LL, Kusano LT, Pereira MG. Diagnosis and control of polypharmacy in the elderly. Rev Saude Publica 2007; 41:1049 - 53; http://dx.doi.org/10.1590/S0034-89102006005000050; PMID: 17992356
   PubMed Web of Science ®Google Scholar
• Wootla B, Lacroix-Desmazes S, Warrington AE, Bieber AJ, Kaveri SV, Rodriguez M. Autoantibodies with enzymatic properties in human autoimmune diseases. J Autoimmun 2011; 37:144 - 50; http://dx.doi.org/10.1016/j.jaut.2011.05.007; PMID: 21624820
   PubMed Web of Science ®Google Scholar
• Schleidgen S, Klingler C, Bertram T, Rogowski WH, Marckmann G. What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Med Ethics 2013; 14:55; http://dx.doi.org/10.1186/1472-6939-14-55; PMID: 24359531
   PubMed Web of Science ®Google Scholar
• Shah RR, Shah DR. Personalized medicine: is it a pharmacogenetic mirage?. Br J Clin Pharmacol 2012; 74:698 - 721; http://dx.doi.org/10.1111/j.1365-2125.2012.04328.x; PMID: 22591598
   PubMed Web of Science ®Google Scholar
• Cascorbi I. Overlapping effects of genetic variation and epigenetics on drug response: challenges of pharmacoepigenomics. Pharmacogenomics 2013; 14:1807 - 9; http://dx.doi.org/10.2217/pgs.13.194; PMID: 24236479
   PubMed Web of Science ®Google Scholar
• Uetrecht J, Naisbitt DJ. Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev 2013; 65:779 - 808; http://dx.doi.org/10.1124/pr.113.007450; PMID: 23476052
   PubMed Web of Science ®Google Scholar
• Henderson PT, Pan CX. Human microdosing for the prediction of patient response. Bioanalysis 2010; 2:373 - 6; http://dx.doi.org/10.4155/bio.10.3; PMID: 21083245
   PubMed Web of Science ®Google Scholar
• Maynard KI. Hormesis pervasiveness and its potential implications for pharmaceutical research and development. Dose Response 2011; 9:377 - 86; http://dx.doi.org/10.2203/dose-response.11-026.Maynard; PMID: 22013400
   PubMed Web of Science ®Google Scholar
• Cascorbi I. Drug interactions--principles, examples and clinical consequences. Dtsch Arztebl Int 2012; 109:546 - 55, quiz 556; PMID: 23152742
   PubMed Web of Science ®Google Scholar
• Ho M, Segre M. Inhibition of cocaine binding to the human dopamine transporter by a single chain anti-idiotypic antibody: its cloning, expression, and functional properties. Biochim Biophys Acta 2003; 1638:257 - 66; http://dx.doi.org/10.1016/S0925-4439(03)00091-7; PMID: 12878327
   PubMed Web of Science ®Google Scholar
• Datta-Mannan A, Witcher DR, Tang Y, Watkins J, Wroblewski VJ. Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor. J Biol Chem 2007; 282:1709 - 17; http://dx.doi.org/10.1074/jbc.M607161200; PMID: 17135257
   PubMed Web of Science ®Google Scholar
• Schlapschy M, Binder U, Börger C, Theobald I, Wachinger K, Kisling S, Haller D, Skerra A. PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins. Protein Eng Des Sel 2013; 26:489 - 501; http://dx.doi.org/10.1093/protein/gzt023; PMID: 23754528
   PubMed Web of Science ®Google Scholar
• Cousens LP, Najafian N, Mingozzi F, Elyaman W, Mazer B, Moise L, Messitt TJ, Su Y, Sayegh M, High K, et al. In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity. J Clin Immunol 2013; 33:Suppl 1 S43 - 9; http://dx.doi.org/10.1007/s10875-012-9762-4; PMID: 22941509
   PubMed Web of Science ®Google Scholar
• Shao L, Hewitt MC. The kinetic isotope effect in the search for deuterated drugs. Drug News Perspect 2010; 23:398 - 404; PMID: 20697607
   PubMed Web of Science ®Google Scholar
• Hollis A, Ahmed Z. Preserving antibiotics, rationally. N Engl J Med 2013; 369:2474 - 6; http://dx.doi.org/10.1056/NEJMp1311479; PMID: 24369073
   PubMed Web of Science ®Google Scholar
• Robinson JA. Max Bergmann lecture protein epitope mimetics in the age of structural vaccinology. J Pept Sci 2013; 19:127 - 40; http://dx.doi.org/10.1002/psc.2482; PMID: 23349031
   PubMed Web of Science ®Google Scholar
• Swamidass SJ, Lu Z, Agarwal P, Butte AJ. Computational approaches to drug repurposing and pharmacology -session introduction. Pac Symp Biocomput 2014; 19:110 - 3
   Google Scholar
• Imai K, Takaoka A. Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer 2006; 6:714 - 27; http://dx.doi.org/10.1038/nrc1913; PMID: 16929325
   PubMed Web of Science ®Google Scholar
• Humphreys G. The health-care challenges posed by population ageing. Bull World Health Organ 2012; 90:82 - 3; PMID: 22423156
   PubMed Web of Science ®Google Scholar
• McMichael AJ. Impediments to comprehensive research on climate change and health. Int J Environ Res Public Health 2013; 10:6096 - 105; http://dx.doi.org/10.3390/ijerph10116096; PMID: 24225646
   PubMed Web of Science ®Google Scholar